Alexander Bald ESA-SRB-NZSE-CaSR 2026 in conjunction with ENSA

Abstracts this author is presenting:

• Use of 3% Hypertonic Saline for Severe and Symptomatic Hyponatraemia: A Five-Year Single-Centre Audit — Joint Poster Session